NO20060402L - 3-amino choman og 2-aminotetralinderivater - Google Patents

3-amino choman og 2-aminotetralinderivater

Info

Publication number
NO20060402L
NO20060402L NO20060402A NO20060402A NO20060402L NO 20060402 L NO20060402 L NO 20060402L NO 20060402 A NO20060402 A NO 20060402A NO 20060402 A NO20060402 A NO 20060402A NO 20060402 L NO20060402 L NO 20060402L
Authority
NO
Norway
Prior art keywords
choman
amino
aminotetraline derivatives
compounds
aminotetraline
Prior art date
Application number
NO20060402A
Other languages
English (en)
Inventor
Amedeo Arturo Failli
Annmarie Louise Sabb
Richard Eric Mewshaw
Dahui Zhou
Deborah Ann Evrard
Steven Edward Lenicek
Uresh Shantilal Shah
Nicole Theriault Hatzenbuhler
Jennifer Ann Inghrim
Reinhardt Bernhard Baudy
John Anthony Butera
Pudukkaraipudur Si Ramamoorthy
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20060402L publication Critical patent/NO20060402L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

3-aminokroman og 2-aminotetralinderivater og sammensetninger inneholdende slike forbindelser er beskrevet. Fremgangsmåter for anvendelse av 3-aminokroman og 2-aminotetralinforbindelser og sammensetninger inneholdende slike forbindelser for behandling av serotoninforstyrrelser, så som depresjon og angst er også beskrevet.
NO20060402A 2003-07-30 2006-01-25 3-amino choman og 2-aminotetralinderivater NO20060402L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49113703P 2003-07-30 2003-07-30
US49179403P 2003-08-01 2003-08-01
US10/898,866 US20050032873A1 (en) 2003-07-30 2004-07-26 3-Amino chroman and 2-amino tetralin derivatives
PCT/US2004/024549 WO2005012291A1 (en) 2003-07-30 2004-07-29 3-amino choman and 2-amino tetralin derivatives

Publications (1)

Publication Number Publication Date
NO20060402L true NO20060402L (no) 2006-04-06

Family

ID=34119805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060402A NO20060402L (no) 2003-07-30 2006-01-25 3-amino choman og 2-aminotetralinderivater

Country Status (15)

Country Link
US (1) US20050032873A1 (no)
EP (1) EP1651637A1 (no)
JP (1) JP2007500718A (no)
KR (1) KR20060054376A (no)
AR (1) AR045180A1 (no)
AU (1) AU2004261649A1 (no)
BR (1) BRPI0413022A (no)
CA (1) CA2533363A1 (no)
CR (1) CR8191A (no)
EC (1) ECSP066336A (no)
IL (1) IL173193A0 (no)
MX (1) MXPA06001008A (no)
NO (1) NO20060402L (no)
TW (1) TW200503705A (no)
WO (1) WO2005012291A1 (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
DE60204229T2 (de) * 2002-12-02 2006-02-02 Schwarz Pharma Ag Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
EP1547592A1 (en) * 2003-12-23 2005-06-29 Schwarz Pharma Ag Intranasal formulation of rotigotine
AU2005250116B2 (en) * 2004-06-01 2011-01-20 F. Hoffmann-La Roche Ag 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
WO2006089053A2 (en) * 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
ES2398934T3 (es) 2005-03-28 2013-03-22 Toyama Chemical Co., Ltd. Proceso de la producción de1-(3-(2-(1-benzotiofen-5-il)etoxi)propil)acetidin-ol o sales del mismo
TW200800959A (en) * 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
JP2008543867A (ja) * 2005-06-17 2008-12-04 ワイス セロトニン阻害剤ならびに５−ｈｔ１ａアゴニストおよびアンタゴニストとして有用な三環系化合物
WO2007109577A1 (en) * 2006-03-17 2007-09-27 Kalypsys, Inc. Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar
CA2654261C (en) 2006-05-19 2017-05-16 Mako Surgical Corp. Method and apparatus for controlling a haptic device
TW200831096A (en) * 2006-11-28 2008-08-01 Wyeth Corp Metabolites of 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof
US20080221193A1 (en) * 2006-12-22 2008-09-11 Wyeth 3-amino chromane derivatives
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
TW200927740A (en) * 2007-11-13 2009-07-01 Bial Portela & Ca Sa Process
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives
DE102010020553A1 (de) 2010-05-14 2011-11-17 Bayer Schering Pharma Aktiengesellschaft Substituierte 8-Alkoxy-2-aminotetralin-Derivate und ihre Verwendung
EP3181550B1 (en) 2010-07-20 2019-11-20 Bayer Intellectual Property GmbH Benzocycloalkenes as antifungal agents
ES2542433T3 (es) 2010-12-17 2015-08-05 Rhodes Technologies Síntesis a baja temperatura de clorhidrato de metilfenidato
CN102746215A (zh) * 2011-04-18 2012-10-24 张兆勇 一种制备高纯度盐酸贝尼地平的方法
US9387203B2 (en) 2012-07-20 2016-07-12 Bayer Pharma Aktiengesellschaft Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof
PT2875003T (pt) 2012-07-20 2017-02-16 Bayer Pharma AG Novos ácidos 5-amino-tetra-hidroquinolina-2-carboxílicos e sua utilização
GB201316410D0 (en) 2013-09-13 2013-10-30 Bial Portela & Ca Sa Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein
UA126056C2 (uk) 2014-04-29 2022-08-10 ЕфЕмСі КОРПОРЕЙШН Піридазинонові гербіциди
US11840541B2 (en) 2014-11-26 2023-12-12 The Trustees Of Columbia University In The City Of New York Opioid receptor modulators
AU2016346303B2 (en) 2015-10-28 2021-01-07 Fmc Corporation Novel pyrdazinone herbicides
CN116514761A (zh) 2016-07-29 2023-08-01 赛诺维信制药公司 化合物、组合物及其用途
EP3490607A4 (en) * 2016-07-29 2020-04-08 Sunovion Pharmaceuticals Inc. COMPOUNDS AND COMPOSITIONS, AND USES THEREOF
TWI785022B (zh) 2017-03-28 2022-12-01 美商富曼西公司 新穎噠嗪酮類除草劑
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
WO2020123699A1 (en) * 2018-12-11 2020-06-18 The Trustees Of Columbia University In The City Of New York Compounds and compositions that cause mycn and/or cmyc degradation and methods of use thereof
KR20210139376A (ko) 2019-03-14 2021-11-22 선오비온 파마슈티컬스 인코포레이티드 이소크로마닐 화합물의 염, 및 이의 결정성 형태, 제조방법, 치료 용도 및 약제학적 조성물
KR20230066313A (ko) * 2020-06-08 2023-05-15 탁토젠 인크 정신 장애 또는 정신적 증강에 유리한 벤조푸란 조성물
WO2023107653A2 (en) * 2021-12-08 2023-06-15 Tactogen Inc Benzofuran salt morphic forms and mixtures for the treatment of mental disorders or mental enhancement

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3671544A (en) * 1970-07-13 1972-06-20 Warner Lambert Co 3,4,4a,9a-tetrahydro-2-(1h)carbazolones
US4319029A (en) * 1979-08-06 1982-03-09 American Home Products Corporation Hydroxyalkanamide tetrahydrocarbazoles
US4235903A (en) * 1979-08-06 1980-11-25 American Home Products Corporation 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use
US4564628A (en) * 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
EP0254989B1 (en) * 1986-07-28 1990-09-26 Whitby Research Incorporated Substituted 2-aminotetralins
US5153225A (en) * 1986-12-10 1992-10-06 Bayer Aktiengesellschaft Substituted basic 2-aminotetralin in pharmaceuticals
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
US5306830A (en) * 1989-04-27 1994-04-26 The Upjohn Company Substituted 3-amino chromans
RU2086535C1 (ru) * 1989-05-31 1997-08-10 Дзе Апджон Компани Производные 1,2,3,4-тетрагидро-2-нафтиламина
US5545755A (en) * 1989-05-31 1996-08-13 The Upjohn Company Therapeutically useful 2-aminotetralin derivatives
DE3919624A1 (de) * 1989-06-15 1990-12-20 Boehringer Ingelheim Kg Neue 2,5-diaminotetraline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
SE8904127D0 (sv) * 1989-12-07 1989-12-07 Astra Ab New biocyclic amino-substituted compounds
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
US5510374A (en) * 1990-04-09 1996-04-23 Adir Et Compagnie 3-aminochroman compounds
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
SE9701438D0 (sv) * 1997-04-17 1997-04-17 Astra Ab A new process
JPH1165435A (ja) * 1997-08-21 1999-03-05 Toyota Motor Corp 車両用地図データ処理装置
CA2470863C (en) * 2001-12-20 2012-05-15 Wyeth Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands

Also Published As

Publication number Publication date
TW200503705A (en) 2005-02-01
CA2533363A1 (en) 2005-02-10
ECSP066336A (es) 2006-07-28
CR8191A (es) 2006-07-14
JP2007500718A (ja) 2007-01-18
BRPI0413022A (pt) 2006-10-03
AU2004261649A1 (en) 2005-02-10
EP1651637A1 (en) 2006-05-03
WO2005012291A1 (en) 2005-02-10
IL173193A0 (en) 2006-06-11
MXPA06001008A (es) 2006-04-11
US20050032873A1 (en) 2005-02-10
KR20060054376A (ko) 2006-05-22
AR045180A1 (es) 2005-10-19

Similar Documents

Publication Publication Date Title
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
NO20056130L (no) Nye substituerte 3-svovelindoler
NO20085373L (no) P38 inhibitorer, deres fremstilling og anvendelse
MEP6508A (xx) Fenil-piperazin derivati kao inhibitori resorbucije serotonina
NO20061845L (no) Fenyl-piperazinderivater som modulatorer for muskarine reseptorer
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
NO20055208L (no) 4-(2-fenylsulfanyl-fenyl)-piperidinderivater som serotonin-reopptaksinhibitorer
NO20061074L (no) Forbindelser og sammensetninger som inbibitorer av reseptortyrosinkinaseaktivitet
SE0301010D0 (sv) Novel compounds
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
CY1108592T1 (el) Διϋδροτετραβεναζινες και φαρμακευτικες συνθεσεις που τις περιεχουν
NO20070855L (no) Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer.
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
EA200602196A1 (ru) Производные пиразола, композиции, содержащие эти соединения, и способы применения
SE0301009D0 (sv) Novel compounds
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
NO20054787D0 (no) Indenderivater som farmasotiske midler
DK1506185T3 (da) Forbindelser og deres anvendelse som 5-HT-inhibitorer
NO20061981L (no) Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20043952L (no) Benzofuran- og benzotiofenderivater som er nyttige ved behandling av hyperproliferative forstyrrelser
NO20055205L (no) 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
WO2004052858A3 (en) Inhibitors of monoamine uptake
NO20061425L (no) Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application